A Phase I Study of Bendamustine and Bevacizumab for Patients With Advanced Cancers.
Phase of Trial: Phase I
Latest Information Update: 04 Jul 2014
At a glance
- Drugs Bendamustine (Primary) ; Bevacizumab (Primary)
- Indications Cancer
- Focus Adverse reactions
- 28 May 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 26 Apr 2013 Status changed from recruiting to active, no longer recruiting as reported by M.D. Anderson Cancer Center.
- 09 Jul 2010 Planned end date changed from 1 Jul 2016 to 1 Jun 2016 as reported by ClinicalTrials.gov.